US lawsuit ‘no effect on strategy’

A threatened legal action against Irish food group Glanbia over alleged misstating of a product’s benefits will not impact the company’s strategy in any way, according to group managing director, Siobhán Talbot.

US law firm Newport Trial Group is alleging that Bio-Engineered Supplements (BNS) — which Glanbia bought in 2011 — misstated the potential benefits of popular bodybuilding supplement, Nitrix, and in doing so has wrongfully taken millions of dollars from consumers.

The law firm filed the complaint in California saying that the possible number of litigants could be in the tens of thousands as it continues to seek consumers who have purchased the supplement to join as litigants.